Processing

Please wait...

Settings

Settings

Goto Application

1. WO2006101118 - APPLICATION OF D-PSICOSE TO SUPPRESSION OF ABNORMAL CIRCADIAN INCREASE IN BLOOD GLUCOSE LEVEL

Publication Number WO/2006/101118
Publication Date 28.09.2006
International Application No. PCT/JP2006/305692
International Filing Date 22.03.2006
Chapter 2 Demand Filed 22.01.2007
IPC
A61K 31/7004 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7004Monosaccharides having only carbon, hydrogen and oxygen atoms
A61P 3/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
04Anorexiants; Antiobesity agents
A61P 3/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
06Antihyperlipidemics
A61P 3/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 9/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
10for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
A23K 1/16 2006.01
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
KFEEDING-STUFFS SPECIALLY ADAPTED FOR ANIMALS; METHODS SPECIALLY ADAPTED FOR PRODUCTION THEREOF
1Animal feeding-stuffs
16supplemented with accessory food factors; Salt blocks
CPC
A23K 20/163
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
KFODDER
20Accessory food factors for animal feeding-stuffs
10Organic substances
163Sugars; Polysaccharides
A23K 50/40
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
KFODDER
50Feeding-stuffs specially adapted for particular animals
40for carnivorous animals, e.g. cats or dogs
A23L 27/30
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT
27Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
30Artificial sweetening agents
A23L 33/10
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
A61K 31/7004
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7004Monosaccharides having only carbon, hydrogen and oxygen atoms
A61P 3/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
04Anorexiants; Antiobesity agents
Applicants
  • 国立大学法人香川大学 NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY [JP]/[JP] (AE, AG, AL, AM, AT, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SI, SK, SL, SM, SN, SY, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW)
  • 徳田 雅明 TOKUDA, Masaaki [JP]/[JP] (UsOnly)
  • 何森 健 IZUMORI, Ken [JP]/[JP] (UsOnly)
  • 松尾 達博 MATSUO, Tatsuhiro [JP]/[JP] (UsOnly)
  • 森本 兼司 MORIMOTO, Kenji [JP]/[JP] (UsOnly)
  • 竹川 薫 TAKEKAWA, Kaoru [JP]/[JP] (UsOnly)
Inventors
  • 徳田 雅明 TOKUDA, Masaaki
  • 何森 健 IZUMORI, Ken
  • 松尾 達博 MATSUO, Tatsuhiro
  • 森本 兼司 MORIMOTO, Kenji
  • 竹川 薫 TAKEKAWA, Kaoru
Agents
  • 須藤 阿佐子 SUDO, Asako
Priority Data
2005-08294823.03.2005JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) APPLICATION OF D-PSICOSE TO SUPPRESSION OF ABNORMAL CIRCADIAN INCREASE IN BLOOD GLUCOSE LEVEL
(FR) APPLICATION DU D-PSICOSE POUR SUPPRIMER L’AUGMENTATION ANORMALE DU RYTHME CIRCADIEN DE LA GLYCEMIE
(JA) D-プシコースの血糖値日内異常上昇抑制の用途
Abstract
(EN)
It is intended to provide a novel application of D-psicose (application to suppression of abnormal circadian increase in blood glucose level). It is a composition for suppressing abnormal circadian increase in plasma glucose level containing D-psicose as an active ingredient. The composition contains D-psicose and/or a derivative thereof. The composition contains D-psicose and/or a derivative thereof as an active ingredient and has a form selected from the group consisting of a sweetener, a seasoning, a food additive, a food material, a food or drink, a health food or drink, a pharmaceutical and an animal feed that can be used for prevention and treatment of diabetes, latent diabetic condition, obesity, hyperlipemia and/or arteriosclerosis, which are diseases requiring sparing of insufficient insulin, amelioration of insulin sensitivity and correction of high blood glucose level, and/or diseases in which a symptom can be improved or an onset can be prevented by suppression of abnormal circadian increase in plasma glucose level. A method for using D-psicose comprising giving D-psicose at a fixed time and suppressing abnormal increase in plasma glucose level throughout a day, characterized by using D-psicose for suppressing abnormal circadian increase in plasma glucose level.
(FR)
Cette composition vise à fournir une nouvelle application du D-psicose (pour supprimer l’augmentation anormale du rythme circadien de la glycémie). Il s’agit d’un composé destiné à supprimer cette augmentation anormale du taux de glucose plasmatique et contenant un ingrédient actif : le D-psicose ou un dérivé de ce dernier. Cette composition contenant du D-psicose ou un de ses dérivés comprend également un élément sélectionné dans le groupe formé par un édulcorant, un assaisonnement, un additif alimentaire, un aliment, un aliment ou une boisson, un aliment ou une boisson diététique, un produit pharmaceutique et un aliment pour animaux pouvant être utilisés pour la prévention et le traitement du diabète, du diabète latent, de l’obésité, de l’hyperlipidémie et de athérosclérose, toutes maladies requérant une épargne de l’insuline insuffisante, une amélioration de la sensibilité à l’insuline et la correction d’une forte glycémie, et des maladies où la suppression d’un rythme circadien anormal de l’augmentation de la glycémie peut améliorer les symptômes et empêcher une apparition de la maladie. L’invention concerne également un procédé basé sur l’administration de D-psicose à heures fixes pour supprimer une augmentation du taux de glucose plasmatique au cours de la journée et réguler ainsi un rythme circadien anormal.
(JA)
 D-プシコースの新規用途(血糖値日内異常上昇抑制の用途)の提供。  D-プシコースを有効成分とする血漿グルコース濃度の日内異常上昇抑制用組成物。D-プシコース、および/または、その誘導体を配合した組成物である。上記組成物は、D-プシコース、および/または、その誘導体を有効成分として配合した、乏しいインスリンの節約、インスリン感受性の改善、および高血糖の是正が求められる疾患、および/または、血漿グルコース濃度の日内異常上昇抑制により症状が改善される、あるいは発病が予防される疾患である糖尿病、潜在的糖尿病状態、肥満症、高脂血症、および/または、動脈硬化症の予防および治療に用いることができる甘味料、調味料、食品添加物、食品素材、飲食品、健康飲食品、医薬品および飼料からなる群から選ばれる形態のものである。D-プシコースを定時に与え一日を通じて血漿グルコース濃度の異常な上昇を抑制することよりなる、D-プシコースを血漿グルコース濃度の日内異常上昇抑制に使用することを特徴とするD-プシコースの使用方法。
Latest bibliographic data on file with the International Bureau